Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Capital Leases: 2022-2023

  • Lexeo Therapeutics' Capital Leases was N/A to $1.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2022, which is N/A change from last year.
  • According to the latest figures from Q3 2023, Lexeo Therapeutics' Capital Leases is $1.4 million, which was down 18.02% from $1.6 million recorded in Q4 2022.
  • Over the past 5 years, Lexeo Therapeutics' Capital Leases peaked at $1.6 million during Q4 2022, and registered a low of $1.4 million during Q3 2023.
  • Over the past 2 years, Lexeo Therapeutics' median Capital Leases value was $1.5 million (recorded in 2022), while the average stood at $1.5 million.